Yamogenin 3-O-neohesperidoside

Details

Top
Internal ID 442982da-095e-40fc-957e-cf95f342c4c6
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins
IUPAC Name (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(1S,2S,4S,5'S,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
SMILES (Canonical) CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)C)OC1
SMILES (Isomeric) C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)C)C)C)OC1
InChI InChI=1S/C39H62O12/c1-18-8-13-39(46-17-18)19(2)28-26(51-39)15-25-23-7-6-21-14-22(9-11-37(21,4)24(23)10-12-38(25,28)5)48-36-34(32(44)30(42)27(16-40)49-36)50-35-33(45)31(43)29(41)20(3)47-35/h6,18-20,22-36,40-45H,7-17H2,1-5H3/t18-,19-,20-,22-,23+,24-,25-,26-,27+,28-,29-,30+,31+,32-,33+,34+,35-,36+,37-,38-,39+/m0/s1
InChI Key HDXIQHTUNGFJIC-SFYWSABLSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C39H62O12
Molecular Weight 722.90 g/mol
Exact Mass 722.42412741 g/mol
Topological Polar Surface Area (TPSA) 177.00 Ų
XlogP 3.00
Atomic LogP (AlogP) 2.39
H-Bond Acceptor 12
H-Bond Donor 6
Rotatable Bonds 5

Synonyms

Top
110996-52-6
CHEBI:10087
(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(1S,2S,4S,5'S,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
C08919
CHEMBL2036080
DTXSID60331660
Q27108575

2D Structure

Top
2D Structure of Yamogenin 3-O-neohesperidoside

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7196 71.96%
Caco-2 - 0.8813 88.13%
Blood Brain Barrier - 0.7000 70.00%
Human oral bioavailability - 0.8143 81.43%
Subcellular localzation Mitochondria 0.7739 77.39%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8976 89.76%
OATP1B3 inhibitior + 0.8663 86.63%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.5750 57.50%
BSEP inhibitior + 0.7121 71.21%
P-glycoprotein inhibitior + 0.6982 69.82%
P-glycoprotein substrate - 0.5395 53.95%
CYP3A4 substrate + 0.7433 74.33%
CYP2C9 substrate - 0.8054 80.54%
CYP2D6 substrate - 0.8216 82.16%
CYP3A4 inhibition - 0.9460 94.60%
CYP2C9 inhibition - 0.9118 91.18%
CYP2C19 inhibition - 0.9113 91.13%
CYP2D6 inhibition - 0.9360 93.60%
CYP1A2 inhibition - 0.8848 88.48%
CYP2C8 inhibition + 0.7377 73.77%
CYP inhibitory promiscuity - 0.8774 87.74%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5291 52.91%
Eye corrosion - 0.9892 98.92%
Eye irritation - 0.9224 92.24%
Skin irritation - 0.5662 56.62%
Skin corrosion - 0.9438 94.38%
Ames mutagenesis - 1.0000 100.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7850 78.50%
Micronuclear - 0.8800 88.00%
Hepatotoxicity - 1.0000 100.00%
skin sensitisation - 0.9240 92.40%
Respiratory toxicity + 0.7556 75.56%
Reproductive toxicity + 0.8667 86.67%
Mitochondrial toxicity - 0.5375 53.75%
Nephrotoxicity - 0.8118 81.18%
Acute Oral Toxicity (c) III 0.4459 44.59%
Estrogen receptor binding + 0.8104 81.04%
Androgen receptor binding + 0.7060 70.60%
Thyroid receptor binding - 0.6010 60.10%
Glucocorticoid receptor binding - 0.5339 53.39%
Aromatase binding + 0.6660 66.60%
PPAR gamma + 0.6615 66.15%
Honey bee toxicity - 0.5718 57.18%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.5300 53.00%
Fish aquatic toxicity + 0.9442 94.42%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.65% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.24% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 96.98% 95.93%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.65% 97.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 93.56% 100.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 90.74% 89.00%
CHEMBL253 P34972 Cannabinoid CB2 receptor 90.36% 97.25%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 89.62% 95.89%
CHEMBL5608 Q16288 NT-3 growth factor receptor 88.25% 95.89%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 88.06% 94.45%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 87.98% 89.05%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 86.68% 95.50%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.24% 86.33%
CHEMBL5255 O00206 Toll-like receptor 4 85.85% 92.50%
CHEMBL237 P41145 Kappa opioid receptor 85.14% 98.10%
CHEMBL218 P21554 Cannabinoid CB1 receptor 84.35% 96.61%
CHEMBL3359 P21462 Formyl peptide receptor 1 83.00% 93.56%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 82.02% 94.08%
CHEMBL2581 P07339 Cathepsin D 81.83% 98.95%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 81.72% 100.00%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 81.63% 94.00%
CHEMBL3430907 Q96GD4 Aurora kinase B/Inner centromere protein 80.44% 97.50%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 80.19% 86.92%

Cross-Links

Top
PubChem 441901
NPASS NPC113044
LOTUS LTS0114629
wikiData Q27108575